Chromosome Disorders: Clinical Trials

2 trials for Chromosome Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow Chromosome Disorders: new trials by email Literature Review of Chromosome Disorders trials Research Report on Chromosome Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Angelman Syndrome (AS) Biomarker Study
Lumbar Puncture, Blood Collection - Angelman Syndrome, Chromosome 15q Duplication (dup15q) Syndrome
Early Phase 1CompletedBiogen202019-12-182022-01-28
Neurophysiological and Acute Pharmacological Studies in FXS Patients
Acamprosate, Lovastatin, Minocycline - Fragile X Syndrome
Early Phase 1CompletedChildren's Hospital Medical Center, Cincinnati292016-01-012021-11-26

Narrower conditions

Angelman Syndrome (1)  ·  Chromosome 15q, trisomy (1)  ·  Fragile X Syndrome (1)  ·  Polyposis Syndrome, Hereditary Mixed, 1 (1)  ·  Syndrome (1)

Broader conditions

Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Nervous System Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Central Nervous System Diseases (1)  ·  Disease (1)  ·  Genetic Diseases, X-Linked (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Imprinting Disorders (1)  ·  Intellectual Disability (1)  ·  Movement Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)

Interventions

Acamprosate (1)  ·  Baclofen (1)  ·  Blood Specimen Collection (1)  ·  Lovastatin (1)  ·  Minocycline (1)  ·  Spinal Puncture (1)

Sponsors

Biogen (1)  ·  Children's Hospital Medical Center, Cincinnati (1)

Countries

United States (2)

Top investigators

Craig A Erickson, M.D. (1)

Results publications

PMID 36167501

NIH funding

U54HD082008 (1)